Trevi Therapeutics (TRVI) Profit After Tax (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.63% |
| Dec 31, 2025 | 29.54% |
| Sep 30, 2025 | 4.06% |
| Jun 30, 2025 | -18.97% |
| Mar 31, 2025 | 9.42% |
| Dec 31, 2024 | 13.80% |
| Sep 30, 2024 | -7.21% |
| Jun 30, 2024 | -13.30% |
| Mar 31, 2024 | -39.39% |
| Dec 31, 2023 | -1.60% |
| Sep 30, 2023 | -7.74% |
| Jun 30, 2023 | -11.62% |
| Mar 31, 2023 | -16.28% |
| Dec 31, 2022 | 33.40% |
| Sep 30, 2022 | -2.66% |
| Jun 30, 2022 | -9.86% |
| Mar 31, 2022 | 13.57% |
| Dec 31, 2021 | -16.88% |
| Sep 30, 2021 | 25.92% |
| Jun 30, 2021 | -17.00% |
| Mar 31, 2021 | 12.48% |
| Dec 31, 2020 | -29.64% |
| Sep 30, 2020 | 0.08% |
| Jun 30, 2020 | 12.85% |
| Mar 31, 2020 | -29.62% |
| Dec 31, 2019 | 11.24% |
| Sep 30, 2019 | -0.26% |
| Jun 30, 2019 | -52.98% |
| Mar 31, 2019 | 19.73% |
| Dec 31, 2018 | -5.80% |
| Sep 30, 2018 | -16.39% |
| Jun 30, 2018 | -19.92% |